1,2-Dimethoxybenzene

CAS No. 91-16-7

1,2-Dimethoxybenzene( —— )

Catalog No. M32051 CAS No. 91-16-7

1,2-Dimethoxybenzene, a natural product secreted by Silene latifolia, is an effective pollinator attractant for the nocturnal moth Hadena bicruris.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    1,2-Dimethoxybenzene
  • Note
    Research use only, not for human use.
  • Brief Description
    1,2-Dimethoxybenzene, a natural product secreted by Silene latifolia, is an effective pollinator attractant for the nocturnal moth Hadena bicruris.
  • Description
    1,2-Dimethoxybenzene, a natural product secreted by Silene latifolia, is an effective pollinator attractant for the nocturnal moth Hadena bicruris.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    91-16-7
  • Formula Weight
    138.1
  • Molecular Formula
    C8H10O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (361.90 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • β-lonone

    β-lonone is an end-ring analog of β-carotenoids which widely distributed in fruit and vegetableswith?anti-proliferative anti-metastatic.

  • L-allo-Isoleucine

    L-alloisoleucine is a branched chain amino acid and is a stereoisomer of L-isoleucine. It is a common constituent of human plasma (albeit at low levels). L-alloisoleucine is produced as a byproduct of isoleucine transamination. Plasma L-alloisoleucine which is derived from L-isoleucine in vivo can be used for the diagnosis of maple syrup urine disease (MSUD) a genetic disorder.

  • Arundic Acid

    Arundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.